Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Cinthia Rosemblit"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/744a23808ca6472ea55f098343ce926c
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
The ErbB/B2 (HER-2/neu) oncogene family plays a critical role in the development and metastatic spread of several tumor types including breast, ovarian and gastric cancer. In breast cancer, HER-2/neu is expressed in early disease development in a lar
Externí odkaz:
https://doaj.org/article/6b7691baf0a644ecb4b6eb67f932ce4e
Autor:
Brian J. Czerniecki, Daniel J. Powell, Jessica A. Cintolo, Jenessa B. Smith, Cinthia Rosemblit, Shuwen Xu, Jashodeep Datta
Vaccination strategies incorporating the immunodominant HLA-A2–restricted HER2/neu-derived peptide 369–377 (HER2369–377) are increasingly utilized in HER2/neu-expressing cancer patients. The failure of postvaccination HER2369–377-specific CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ab4cf3056b2ab26d7fd68879a9cc7f
https://doi.org/10.1158/2326-6066.c.6548858
https://doi.org/10.1158/2326-6066.c.6548858
Autor:
Brian J. Czerniecki, Daniel J. Powell, Jessica A. Cintolo, Jenessa B. Smith, Cinthia Rosemblit, Shuwen Xu, Jashodeep Datta
Figure S1: HER2high cells are susceptible to NK-mediated ADCC, but not HER2369-377-sensitized CD8+ T-cell-mediated cytotoxicity. Figure S2: Cell line-specific IFN-γ receptor expression and impact of IFN-γ dose titration on MHC class I expression. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63288f47ff52bbdbc6613b914a1564f3
https://doi.org/10.1158/2326-6066.22538681
https://doi.org/10.1158/2326-6066.22538681
Autor:
Mateo N. Campos Haedo, Maria C. Diaz Flaque, Helena A. Sterle, Johanna A. Diaz Albuja, Maria F. Cayrol, Maria M. Debernardi, Marina Perona, Guillermo J. Juvenal, Graciela A. Cremaschi, Cinthia Rosemblit
Publikováno v:
Cancer Research. 83:3073-3073
Background: Thyroid carcinoma (TC) is the most common endocrine neoplasia. Its incidence has increased in the last 40 years worldwide. Sorafenib (Sor), a tyrosine kinase inhibitor (TKI), was approved for the treatment of TC, being hypothyroidism the
Autor:
Mateo Campos Haedo, M Florencia Cayrol, Graciela Cremaschi, M Mercedes Debernardi, Johanna Diaz Albuja, M Celeste Díaz Albuja, M Alejandra Paulazo, Cinthia Rosemblit, Helena Sterle
Publikováno v:
Journal of the Endocrine Society. 6:A876-A876
Despite the development of novel therapies, breast cancer (BC) tumors are treated with conventional therapy eventually. Due to tumor heterogeneity, it is necessary to define new biomarkers to identify groups with different molecular characteristic an
Autor:
Cinthia Rosemblit, Lisa Thomasz, Luciano Rossich, Guillermo Juvenal, Marina Perona, Mario A. Pisarev, Carla Rodríguez, Maria Alejandra Dagrosa, Graciela Cremaschi
Publikováno v:
Molecular and Cellular Endocrinology. 2018;478:141-150
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Fil: Perona, Marina. Comisión Nacional de Energía Atómica. Departamento de Radiobiología; Argentina Fil: Perona, Marina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Thomasz, Lisa. Comisión Nacional de Energía At
Autor:
Marcela F. Bolontrade, Helena Andrea Sterle, María Celeste Díaz Flaqué, Maria Alejandra Paulazo, Cinthia Rosemblit, L. Colombo, Florencia Cayrol, Ximena Hildebrandt, Graciela Cremaschi, Luciana M. Gutierrez, Vanina Araceli Medina, Matías Valenzuela Alvarez, Alicia Juana Klecha, María Laura Barreiro Arcos
Publikováno v:
Postprint de artículo publicado en Endocrine-related cancer. 2021, 28 (7)
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Fil: Sterle, Helena Andrea. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas. Laboratorio de Neuroinmunomodulación y Oncología Molecular; Argentina Fil: Sterle, Helena Andrea. Conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6398cd2093841108f9d6eb38f1666a0
https://repositorio.uca.edu.ar/handle/123456789/14115
https://repositorio.uca.edu.ar/handle/123456789/14115
Autor:
Johanna Abigail Díaz Albuja, María Celeste Díaz Flaqué, Florencia Cayrol, Maria Mercedes Debernardi, Graciela Cremaschi, Cinthia Rosemblit
Publikováno v:
Journal of the Endocrine Society
Bexarotene (Bex) is an oral retinoid-X-receptor agonist that is effective for the treatment of early and advanced-stage in cutaneous T cell lymphoma. There are ongoing clinical trials to determine its role in both breast cancer treatment and preventi
Autor:
María Celeste Díaz Flaqué, María del Rosario Aschero, Blanca Issé, Johanna Abigail Díaz Albuja, Maria Florencia Cayrol, Helena Andrea Sterle, Graciela Cremaschi, Cinthia Rosemblit, Ricardo N. Farías, Leandro Cerchietti
Publikováno v:
Oncotarget. 2019;10(32):3051-3065
Oncotarget
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Scopus-Elsevier
Oncotarget
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Scopus-Elsevier
Thyroid hormones (THs) 3,3′,5-triiodo-L-thyronine (T3) and L-thyroxine (T4) are important regulators of the metabolism and physiology of most normal tissues.Cytochrome P450 family 3A members are drug metabolizing enzymes involved in theactivation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29647e78209ed1a995f63e7a95a7c43
https://repositorio.uca.edu.ar/handle/123456789/8674
https://repositorio.uca.edu.ar/handle/123456789/8674